| BioLife Solutions develops, manufactures and markets bioproduction tools and services to the cell and gene therapy industry. Co. has five main offerings: biopreservation media, which includes HypoThermosol® FRS and CryoStor® products; automated thawing devices, which include automated vial and cryobag thawing products; cloud connected smart shipping containers, which include evo.is cloud app that allows biologic products to be traced and tracked in real time; freezer and storage technology and related components, which include liquid nitrogen laboratory freezers, cryogenic equipment and accessories; and biological and pharmaceutical material storage, which provides cold chain logistics. We show 35 historical shares outstanding datapoints in our BLFS shares outstanding history coverage, used to compute BLFS market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BLFS market cap history over the course of time is important for investors
interested in comparing BLFS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BLFS versus a peer is one thing; comparing
BLFS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BLFS can fluctuate over the course of history.
With this page we aim to empower investors researching BLFS by allowing them to research the BLFS market cap history.